April 18, 2020 / Ken Alltucker, USA TODAY When Aimee Blou heard the lupus drug she has relied on for more than a decade promoted as a coronavirus antidote, she visited her pharmacist. The 40-year-old woman from Stockton, California, was told the decades-old antimalarial drug commonly prescribed for lupus and rheumatoid arthritis was in short supply. She …